| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1982) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | C01AA04 |
| UNII: | E90NZP2L9U |
| InChI Key | WDJUZGPOPHTGOT-XUDUSOBPSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C41H64O13 |
| Molecular Weight | 764.95 |
| AlogP | 3.25 |
| Hydrogen Bond Acceptor | 13.0 |
| Hydrogen Bond Donor | 5.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 182.83 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 54.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | 8 | - | - | ||
|
Ion channel
Other ion channel
Phospholemman family
|
- | 8 | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 57 | |
|
Transporter
Primary active transporter
ATP-binding cassette
ABCB subfamily
|
- | 31000 | - | - | - | |
|
Transporter
Primary active transporter
P-type ATPase
Sodium potassium ATPase
|
- | 8 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Cystic Fibrosis | 2 | D003550 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 71-63-6 |
| ChEBI | 28544 |
| ChEMBL | CHEMBL254219 |
| DrugBank | DB01396 |
| DrugCentral | 881 |
| EPA CompTox | DTXSID0022933 |
| FDA SRS | E90NZP2L9U |
| Human Metabolome Database | HMDB0015468 |
| Guide to Pharmacology | 6782 |
| KEGG | C06955 |
| PDB | F9R |
| PharmGKB | PA449316 |
| PubChem | 441207 |
| SureChEMBL | SCHEMBL20940 |
| ZINC | ZINC000095862733 |